BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28416821)

  • 1. Pathogenic variants that alter protein code often disrupt splicing.
    Soemedi R; Cygan KJ; Rhine CL; Wang J; Bulacan C; Yang J; Bayrak-Toydemir P; McDonald J; Fairbrother WG
    Nat Genet; 2017 Jun; 49(6):848-855. PubMed ID: 28416821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hotspot exons are common targets of splicing perturbations.
    Glidden DT; Buerer JL; Saueressig CF; Fairbrother WG
    Nat Commun; 2021 May; 12(1):2756. PubMed ID: 33980843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future directions for high-throughput splicing assays in precision medicine.
    Rhine CL; Neil C; Glidden DT; Cygan KJ; Fredericks AM; Wang J; Walton NA; Fairbrother WG
    Hum Mutat; 2019 Sep; 40(9):1225-1234. PubMed ID: 31297895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massively parallel reporter assays discover de novo exonic splicing mutants in paralogs of Autism genes.
    Rhine CL; Neil C; Wang J; Maguire S; Buerer L; Salomon M; Meremikwu IC; Kim J; Strande NT; Fairbrother WG
    PLoS Genet; 2022 Jan; 18(1):e1009884. PubMed ID: 35051175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.
    Xiong HY; Alipanahi B; Lee LJ; Bretschneider H; Merico D; Yuen RK; Hua Y; Gueroussov S; Najafabadi HS; Hughes TR; Morris Q; Barash Y; Krainer AR; Jojic N; Scherer SW; Blencowe BJ; Frey BJ
    Science; 2015 Jan; 347(6218):1254806. PubMed ID: 25525159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-Binding Proteins: Splicing Factors and Disease.
    Fredericks AM; Cygan KJ; Brown BA; Fairbrother WG
    Biomolecules; 2015 May; 5(2):893-909. PubMed ID: 25985083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SnapShot: Spliceosome Dynamics III.
    Wahl MC; Lührmann R
    Cell; 2015 Jul; 162(3):690-690.e1. PubMed ID: 26232231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease.
    Claverie-Martin F; Gonzalez-Paredes FJ; Ramos-Trujillo E
    RNA Biol; 2015; 12(4):369-74. PubMed ID: 25757501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro iCLIP-based modeling uncovers how the splicing factor U2AF2 relies on regulation by cofactors.
    Sutandy FXR; Ebersberger S; Huang L; Busch A; Bach M; Kang HS; Fallmann J; Maticzka D; Backofen R; Stadler PF; Zarnack K; Sattler M; Legewie S; König J
    Genome Res; 2018 May; 28(5):699-713. PubMed ID: 29643205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-mRNA splicing in the new millennium.
    Hastings ML; Krainer AR
    Curr Opin Cell Biol; 2001 Jun; 13(3):302-9. PubMed ID: 11343900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
    Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
    Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multiplexed Assay for Exon Recognition Reveals that an Unappreciated Fraction of Rare Genetic Variants Cause Large-Effect Splicing Disruptions.
    Chong R; Insigne KD; Yao D; Burghard CP; Wang J; Hsiao YE; Jones EM; Goodman DB; Xiao X; Kosuri S
    Mol Cell; 2019 Jan; 73(1):183-194.e8. PubMed ID: 30503770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splicing mutations in human genetic disorders: examples, detection, and confirmation.
    Anna A; Monika G
    J Appl Genet; 2018 Aug; 59(3):253-268. PubMed ID: 29680930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of pathogenic gene mutations in
    Ito K; Patel PN; Gorham JM; McDonough B; DePalma SR; Adler EE; Lam L; MacRae CA; Mohiuddin SM; Fatkin D; Seidman CE; Seidman JG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7689-7694. PubMed ID: 28679633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and Regulation of Alternative Pre-mRNA Splicing.
    Lee Y; Rio DC
    Annu Rev Biochem; 2015; 84():291-323. PubMed ID: 25784052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
    Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
    Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.
    Zheng ZM; Huynen M; Baker CC
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14088-93. PubMed ID: 9826658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools.
    Soukarieh O; Gaildrat P; Hamieh M; Drouet A; Baert-Desurmont S; Frébourg T; Tosi M; Martins A
    PLoS Genet; 2016 Jan; 12(1):e1005756. PubMed ID: 26761715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNRP-27, the
    Zahler AM; Rogel LE; Glover ML; Yitiz S; Ragle JM; Katzman S
    RNA; 2018 Oct; 24(10):1314-1325. PubMed ID: 30006499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease.
    Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
    Gene; 2014 Aug; 546(2):243-9. PubMed ID: 24907393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.